Investing.com - Financial Markets Worldwide
Open in App

LENZ Therapeutics Inc (LENZ)

NASDAQ
Currency in USD
9.29
-0.47(-4.82%)
Closed·
After Hours
9.290.00(0.00%)
·

LENZ Earnings

Advanced Earnings Insights
Latest Release
Mar 24, 2026
EPS / Forecast
-1.16 / -0.76
Revenue / Forecast
1.59M / --
EPS Revisions
a
a
Unlock
Last 90 days
Release Date
Period End
EPS
/Forecast
Revenue
/Forecast
EPS Surprise %
Revenue Surprise %
Reaction
12/2025-1.16/-0.7601.59M/---52.63%--Free Sign Up
09/2025-0.590/-0.40012.50M/---47.5%--Free Sign Up
06/2025-0.530/-0.6105.00M/--+13.11%--Free Sign Up
03/2025-0.530/-0.470--/---12.77%--Free Sign Up
12/2024-0.460/-0.100--/---360%--Free Sign Up
03/2024--/-0.770--/0.000----Free Sign Up
12/2023--/-0.910--/0.000----Free Sign Up
09/2023-0.240/-0.240--/0.0000%--Free Sign Up
06/2023-6.79/-0.9700.000/0.000-600%--Free Sign Up
03/2023-3.01/-0.3960.000/0.000-660.68%--Free Sign Up

All numbers in USD

LENZ Therapeutics Inc Earnings Call Summary for Q4/2025

  • LENZ reported $1.6M Q4 revenue from VIZZ presbyopia treatment launch; holds $292.3M cash with zero debt but posted $35.9M net loss.
  • Operating expenses surged 43% sequentially to $40M; net loss per share widened to $1.16 from $0.46 year-over-year in Q4.
  • Stock plunged 12% post-earnings to $10.5, near 52-week low, down 73% over six months despite analyst targets of $35-$62.
  • Company projects Q1 2026 VIZZ sales exceeding 45,000 boxes; plans to allocate 75-80% of expenses to sales/marketing with 90% gross margin.
  • Executives emphasized strong liquidity position to fund growth while facing investor concerns over sustained losses and elevated cash burn rate.
Last Updated: 24/03/2026, 15:00
Read Full Transcript

Earnings News

Show More

FAQ

What Is LENZ Therapeutics's Earnings Per Share (TTM)?

The LENZ Therapeutics EPS (TTM) is -2.85.
Install Our App
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2026 - Fusion Media Limited. All Rights Reserved.